EHop-016

貨號 Cat. No.
S7319
規格 Size
10mg、25mg
品牌 Brand
Selleckchem

Description

 



EHop-016
Catalog No.S7319

EHop-016 is a specific Rac GTPase inhibitor with IC50 of 1.1 μM for Rac1, equally potent inhibition for Rac3.


















Size Price Stock Quantity  
















10mg USD 122 In stock  
0
 
1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
10
 
25mg USD 214 In stock  
0
 
1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
10
 




Distributor Tel: +886-2-2827-1197jimmy@new.abscience.com.tw


Biological Activity







































Description EHop-016 is a specific Rac GTPase inhibitor with IC50 of 1.1 μM for Rac1, equally potent inhibition for Rac3.
Targets Rac1          
IC50 1.1 μM [1]          
In vitro Rac inhibition by EHop-016 increases the activity of the closely related Rho GTPase RhoA by a compensatory mechanism. In MDA-MB-435 cells, EHop-016 (2-5 μM) inhibits association of active Vav2 with Rac1(G15A) mutant fusion protein, and reduces Rac-regulated cell functions including lamellipodia formation and cell migration. In addition, EHop-016 inhibits cell viability of MDA-MB-435 cells with IC50 of 10 μM. [1] EHop-016 also inhibits KITD814V-induced growth in SM and AML patients-derived cells. [2]
In vivo Treatment of KITD814V-bearing cells with EHop-016 significantly enhances the survival of leukemic mice. [2]
Features  

Protocol(Only for Reference)


Kinase Assay: [1]









Rac Activity Assays Rac activity is determined from lysates of the MDA-MB-435 and MDA-MB-231 human metastatic cancer cell lines (from ATCC). Cancer cells in culture medium (DMEM, 10% FBS, pH 7.5) are treated with vehicle (0.1% DMSO) or varying concentrations of EHop-016 (0–10 μM) for 24 h. Rac1 activity is determined using the G-LISA Rac1 activation assay kit.

Cell Assay: [1]





















Cell lines MDA-MB-231, MDA-MB-435, or MCF-10A cells
Concentrations ~10 μM
Incubation Time 24 hours
Method MDA-MB-231, MDA-MB-435, or MCF-10A mammary epithelial cells (from ATCC) are incubated in vehicle (0.1% DMSO) or varying concentrations of EHop-016 (0–10 μM) for 24 h. Cell viability is measured using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide cell survival and proliferation kit according to the manufacturer’s instructions.

Animal Study: [2]





















Animal Models KITD814V-bearing mice.
Dosages 2.5 μM
Administration KITD814V-bearing 32D cells with EHop-016 are administered by i.v. injection.
Solubility 1% DMSO/30% polyethylene glycol/1% Tween 80, 30 mg/mL

1


References


Chemical Information


Download EHop-016 SDF


 

















Molecular Weight (MW) 430.55
Formula

C25H30N6O


CAS No. 1380432-32-5















Storage 3 years -20℃Powder
6 months-80℃in DMSO
Syonnyms N/A

 


























Solubility (25°C) * In vitro DMSO 86 mg/mL (199 mM)
Water <1 mg/mL (<1 mM)
Ethanol <1 mg/mL (<1 mM)
In vivo 1% DMSO/30% polyethylene glycol/1% Tween 80, 30 mg/mL
* <1 mg/ml means slightly soluble or insoluble.

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.


 








Chemical Name N4-(9-Ethyl-9H-carbazol-3-yl)-N2-(3-morpholin-4-yl-propyl)-pyrimidine-2,4-diamine

 


 


 

詢價 / 洽詢此產品

同品牌其他產品

回到產品列表

▲ LINE
諮詢